MGNX – Macrogenics Inc
MacroGenics, Inc.MGNX
$1.58Name : MacroGenics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $99,682,680.00
EPSttm : -0.88
MacroGenics, Inc.
$1.58
1.28%$0.02Float Short %
7.03
Margin Of Safety %
Put/Call OI Ratio
0.24
EPS Next Q Diff
0.34
EPS Last/This Y
0.44
EPS This/Next Y
-2.03
Price
1.58
Target Price
4.75
Analyst Recom
2.5
Performance Q
-5.95
Relative Volume
0.85
Beta
1.66
Ticker: MGNX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | MGNX | 1.45 | 0.35 | 0.00 | 3408 |
| 2025-07-07 | MGNX | 1.355 | 0.35 | 0.00 | 3408 |
| 2025-07-08 | MGNX | 1.47 | 0.34 | 0.00 | 3367 |
| 2025-07-09 | MGNX | 1.6 | 0.34 | 0.01 | 3373 |
| 2025-07-10 | MGNX | 1.585 | 0.32 | 0.00 | 3476 |
| 2025-07-11 | MGNX | 1.61 | 0.32 | 16.00 | 3477 |
| 2025-07-14 | MGNX | 1.58 | 0.31 | 0.00 | 3460 |
| 2025-07-15 | MGNX | 1.49 | 0.31 | 0.08 | 3461 |
| 2025-07-16 | MGNX | 1.525 | 0.31 | 1.50 | 3536 |
| 2025-07-17 | MGNX | 1.545 | 0.31 | 0.00 | 3531 |
| 2025-07-18 | MGNX | 1.485 | 0.31 | 0.31 | 3541 |
| 2025-07-21 | MGNX | 1.48 | 0.42 | 0.01 | 1992 |
| 2025-07-22 | MGNX | 1.565 | 0.41 | 0.00 | 2052 |
| 2025-07-23 | MGNX | 1.81 | 0.39 | 0.00 | 2099 |
| 2025-07-24 | MGNX | 1.785 | 0.09 | 0.00 | 7155 |
| 2025-07-25 | MGNX | 1.72 | 0.15 | 0.20 | 4559 |
| 2025-07-28 | MGNX | 1.685 | 0.15 | 4.00 | 4579 |
| 2025-07-29 | MGNX | 1.59 | 0.16 | 0.00 | 4604 |
| 2025-07-30 | MGNX | 1.55 | 0.16 | 1.37 | 4599 |
| 2025-07-31 | MGNX | 1.57 | 0.24 | 0.00 | 5200 |
| 2025-08-01 | MGNX | 1.58 | 0.24 | 0.00 | 5180 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | MGNX | 1.46 | 142.7 | - | -0.63 |
| 2025-07-07 | MGNX | 1.35 | 142.7 | - | -0.63 |
| 2025-07-08 | MGNX | 1.47 | 142.7 | - | -0.63 |
| 2025-07-09 | MGNX | 1.59 | 142.7 | - | -0.63 |
| 2025-07-10 | MGNX | 1.58 | 142.7 | - | -0.63 |
| 2025-07-11 | MGNX | 1.61 | 142.7 | - | -0.63 |
| 2025-07-14 | MGNX | 1.58 | 142.7 | - | -0.63 |
| 2025-07-15 | MGNX | 1.49 | 142.7 | - | -0.63 |
| 2025-07-16 | MGNX | 1.52 | 142.7 | - | -0.63 |
| 2025-07-17 | MGNX | 1.54 | 142.7 | - | -0.63 |
| 2025-07-18 | MGNX | 1.48 | 142.7 | - | -0.63 |
| 2025-07-21 | MGNX | 1.49 | 142.7 | - | -0.63 |
| 2025-07-22 | MGNX | 1.57 | 142.7 | - | -0.63 |
| 2025-07-23 | MGNX | 1.81 | 142.7 | - | -0.63 |
| 2025-07-24 | MGNX | 1.78 | 142.7 | - | -0.63 |
| 2025-07-25 | MGNX | 1.71 | 142.7 | - | -0.63 |
| 2025-07-28 | MGNX | 1.69 | 142.7 | - | -0.63 |
| 2025-07-29 | MGNX | 1.58 | 142.7 | - | -0.63 |
| 2025-07-30 | MGNX | 1.54 | 142.7 | - | -0.63 |
| 2025-07-31 | MGNX | 1.56 | 142.7 | - | -0.63 |
| 2025-08-01 | MGNX | 1.58 | 142.7 | - | -0.63 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | MGNX | -0.01 | -26.16 | 9.55 |
| 2025-07-07 | MGNX | -0.01 | -26.16 | 9.55 |
| 2025-07-08 | MGNX | -0.01 | -26.16 | 9.55 |
| 2025-07-09 | MGNX | -0.01 | -26.16 | 9.55 |
| 2025-07-10 | MGNX | -0.01 | -26.16 | 9.55 |
| 2025-07-11 | MGNX | -0.01 | -26.16 | 7.81 |
| 2025-07-14 | MGNX | -0.01 | -5.03 | 7.81 |
| 2025-07-15 | MGNX | -0.01 | -5.03 | 7.81 |
| 2025-07-16 | MGNX | -0.01 | -5.03 | 7.81 |
| 2025-07-17 | MGNX | -0.01 | -5.03 | 7.81 |
| 2025-07-18 | MGNX | -0.01 | -5.03 | 7.81 |
| 2025-07-21 | MGNX | -0.01 | -5.00 | 7.81 |
| 2025-07-22 | MGNX | -0.01 | -5.00 | 7.81 |
| 2025-07-23 | MGNX | -0.01 | -5.00 | 7.81 |
| 2025-07-24 | MGNX | -0.01 | -5.00 | 7.81 |
| 2025-07-25 | MGNX | -0.01 | -5.00 | 7.03 |
| 2025-07-28 | MGNX | -0.01 | -12.66 | 7.03 |
| 2025-07-29 | MGNX | -0.01 | -12.66 | 7.03 |
| 2025-07-30 | MGNX | -0.01 | -12.66 | 7.03 |
| 2025-07-31 | MGNX | -0.01 | -12.66 | 7.03 |
| 2025-08-01 | MGNX | -0.01 | -12.66 | 7.03 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.65
Avg. EPS Est. Current Quarter
0.38
Avg. EPS Est. Next Quarter
-0.31
Insider Transactions
-0.01
Institutional Transactions
-12.66
Beta
1.66
Average Sales Estimate Current Quarter
28
Average Sales Estimate Next Quarter
23
Fair Value
Quality Score
38
Growth Score
36
Sentiment Score
7
Actual DrawDown %
95.7
Max Drawdown 5-Year %
-97
Target Price
4.75
P/E
Forward P/E
PEG
P/S
0.65
P/B
1.26
P/Free Cash Flow
EPS
-0.89
Average EPS Est. Cur. Y
-0.63
EPS Next Y. (Est.)
-2.66
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-36.23
Relative Volume
0.85
Return on Equity vs Sector %
-94.3
Return on Equity vs Industry %
-75.6
EPS 1 7Days Diff
1.2
EPS 1 30Days Diff
2.26
EBIT Estimation
MacroGenics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 341
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
stock quote shares MGNX – Macrogenics Inc Stock Price stock today
news today MGNX – Macrogenics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MGNX – Macrogenics Inc yahoo finance google finance
stock history MGNX – Macrogenics Inc invest stock market
stock prices MGNX premarket after hours
ticker MGNX fair value insiders trading